Brief Reports
Copyright ©The Author(s) 2001.
World J Gastroenterol. Oct 15, 2001; 7(5): 698-701
Published online Oct 15, 2001. doi: 10.3748/wjg.v7.i5.698
Table 1 Composition and dosage of TPN solution (kg¯¹•d¯¹)
Composition+MetTPN-MetTPN
250 g•L¯¹ Glucose/m100100
200 g•L¯¹ Intralipid/mL3535
+Met amino acid solution/mL1000
-Met amino acid solution/mL0100
Non-protein energy/J710710
Total nitrogen/g1.301.03
Total volume/mL235235
Table 2 Body mass, tumor diameter and DNA index of tumor cells after TPN (mean ± SD)
TPN solutionmb/g
dt/mm
DNA index
Pre-TPNPost-TPNPre-TPNPost-TPNPre-TPNPost-TPN
+MetTPN242 ± 20243 ± 2011.2 ± 1.014.7 ± 0.7b1.13 ± 0.241.21 ± 0.26
-MetTPN248 ± 20245 ± 1811.5 ± 1.26.9 ± 0.8ad1.15 ± 0.211.12 ± 0.23
+MetTPN+5-FU245 ± 13233 ± 12b11.1 ± 1.19.3 ± 0.8a1.15 ± 0.031.08 ± 0.02a
-MetTPN+5-FU245 ± 14225 ± 13b11.4 ± 0.95.5 ± 0.5bc1.15 ± 0.031.02 ± 0.02bc
Table 3 Change of tumor cell cycles after TPN (mean ± SD, %)
TPN solutionS
G2M
G0/G1
Pre-TPNPost-TPNPre-TPNPost-TPNPre-TPNPost-TPN
+MetTPN6.2 ± 1.210.3 ± 1.4b10.5 ± 1.116.6 ± 1.4a83.4 ± 1.973.1 ± 1.8b
-MetTPN6.4 ± 1.028.5 ± 1.0ac11.2 ± 1.18.3 ± 1.5ad82.4 ± 0.963.2 ± 5.5a
+MetTPN+5-FU6.6 ± 0.34.5 ± 0.5a12.6 ± 0.59.7 ± 1.2a80.8 ± 0.385.8 ± 1.2b
-MetTPN+5-FU6.5 ± 0.74.5 ± 0.3a12.4 ± 0.96.2 ± 0.5bc80.1 ± 0.589.3 ± 0.7b
Table 4 Serum FAA value (mean ± SD, μmol•L¯¹)
+MetTPN-MetTPN
Asp36.1 ± 1.288.9 ± 10.3a
Glu27.3 ± 4.2193.2 ± 17.4a
Ser124.8 ± 21.5231.5 ± 32.3a
Gly116.9 ± 18.3286.7 ± 21.9a
Gln103.4 ± 14.490.1 ± 10.3
His11.2 ± 1.525.0 ± 3.6
Thr53.5 ± 3.893.2 ± 7.1a
Ala138.7 ± 30.1218.8 ± 31.4a
Arg83.6 ± 9.4173.4 ± 25.1a
Pro33.9 ± 8.279.7 ± 13.4
Tyr20.8 ± 5.144.8 ± 6.3
Val88.4 ± 14.131.6 ± 1.6
Met76.1 ± 1.310.9 ± 3.1b
Cys87.3 ± 3.243.2 ± 5.4b
Ile5.4 ± 1.110.1 ± 1.2
Leu34.2 ± 1.355.2 ± 4.3
Phe22.1 ± 2.243.1 ± 2.9
Trp42.5 ± 3.650.7 ± 4.4
Lys212.4 ± 43.1387.8 ± 58.3a